Liu Dongfang Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$50,024.00

Insider Activity of Liu Dongfang

According to the SEC Form 4 filings, Liu Dongfang, being in a position of

  1. CHIEF MEDICAL OFFICER at Nuvation Bio Inc.,
    оver the last 12 months, has bought 0 shares, and sold 270000 shares for $1.87M,
    over all time since 2025-05-02, has bought 0 shares, and sold 290000 shares for $1.92M.

Biography of Liu Dongfang

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,867,3577100

Comparison of Insiders on Amount of Buys and Sells

2026-04-17SaleNuvation Bio Inc.
NUVB
CHIEF MEDICAL OFFICER
50,000
0.0143%
$5.02$251,000+10.24%
2025-12-01SaleNuvation Bio Inc.
NUVB
CHIEF MEDICAL OFFICER
150,000
0.0435%
$7.82$1.17M-28.68%
2025-11-26SaleNuvation Bio Inc.
NUVB
CHIEF MEDICAL OFFICER
10,000
0.0029%
$8.00$80,000-29.78%
2025-11-25SaleNuvation Bio Inc.
NUVB
CHIEF MEDICAL OFFICER
10,000
0.0031%
$7.50$75,000-28.55%
2025-11-20SaleNuvation Bio Inc.
NUVB
CHIEF MEDICAL OFFICER
20,000
0.0058%
$7.00$140,074-19.54%
2025-11-19SaleNuvation Bio Inc.
NUVB
CHIEF MEDICAL OFFICER
15,000
0.0031%
$5.10$76,553-21.12%
2025-11-17SaleNuvation Bio Inc.
NUVB
CHIEF MEDICAL OFFICER
15,000
0.0045%
$4.76$71,475+20.77%
2025-05-02SaleNuvation Bio Inc.
NUVB
CHIEF MEDICAL OFFICER
20,000
0.006%
$2.50$50,024+74.19%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.